Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02693548 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Spanish Familial Hypercholesterolaemia Cohort Study

Study acronym: SAFEHEART
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site details revisedv8
  2. 2 versions Re-verified since Feb 22, 2024, no change to tracked fieldsv6-v7
  3. Primary and study completion dates: Oct 2022 to Oct 2030v5
  4. Re-verified, no change to tracked fieldsv4
  5. Primary and study completion dates: Oct 2020 to Oct 2022v3
  6. Primary and study completion dates: Oct 2017 to Oct 2020
    • Site details revised
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
SAFEHEART is a large, on-going registry study in molecularly defined patients with heterozygous FH treated in Spain.
Trial Details
NCT Number NCT02693548
Lead Sponsor Fundación Hipercolesterolemia Familiar
Collaborators: Instituto de Salud Carlos III, Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Conditions
(from sponsor)		 Familial Hypercholesterolaemia
Related terms Cardiovascular Diseases, Hyperlipoproteinemia Type II
Enrollment 4,141 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov